Could Patients With Inflammatory Bowel Disease Treated With Immunomodulators or Biologics Be at Lower Risk for Severe Forms of COVID-19?
- PMID: 32407807
- PMCID: PMC7214317
- DOI: 10.1053/j.gastro.2020.05.026
Could Patients With Inflammatory Bowel Disease Treated With Immunomodulators or Biologics Be at Lower Risk for Severe Forms of COVID-19?
Comment in
-
Cytokine Storm in IBD: Balancing the Risks of IBD Medical Therapy.Gastroenterology. 2021 Apr;160(5):1878-1880. doi: 10.1053/j.gastro.2020.12.073. Epub 2021 Jan 5. Gastroenterology. 2021. PMID: 33417936 No abstract available.
Comment on
-
Characteristics and Prognosis of Patients With Inflammatory Bowel Disease During the SARS-CoV-2 Pandemic in the Basque Country (Spain).Gastroenterology. 2020 Aug;159(2):781-783. doi: 10.1053/j.gastro.2020.04.043. Epub 2020 Apr 21. Gastroenterology. 2020. PMID: 32330477 Free PMC article. No abstract available.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical